|
|
||||||||
Original Research |
1 Dipartimento di Scienze Biomorfologiche e Funzionali, Università degli
Studi di Napoli Federico II, Via Posillipo 196, 80123, Naples, Italy.
2 National Research Council Napoli, Institute of Bio-structure and Bio-imaging,
SDN Foundation, Naples, Italy.
3 Dipartimento di Chirurgia, Università degli Studi di Napoli Federico
II, Naples, Italy.
OBJECTIVE. The purpose of our study was to compare dual-time-point 18F-FDG PET/CT, performed with the patient in the prone position, and contrast-enhanced MRI in patients with suspected breast malignancy.
SUBJECTS AND METHODS. Forty-four patients with 55 breast lesions
underwent two PET/CT scans (dual-time-point imaging) in the prone position and
breast MRI. Sensitivity, specificity, and overall accuracy were calculated. In
addition, the average percentage of change in standard uptake values
(
%SUVmax) between time point 1 and time point 2 was
calculated for PET/CT. A final histopathologic diagnosis was available for all
patients.
RESULTS. MRI showed an overall accuracy of 95%, with sensitivity and
specificity of 98% and 80%. Conversely, dual-time-point PET/CT showed an
accuracy of 84% for lesions with an SUVmax
2.5 or with a
positive
%SUVmax, with sensitivity and specificity of 80%
and 100% versus 69% accuracy, 62% sensitivity (both, p < 0.001),
and 100% specificity (p not significant) for single-time-point
PET/CT. On PET/CT, malignant lesions showed an increase in FDG between time
points 1 and 2, with a
%SUVmax of 11 ± 24. Benign
lesions showed either no change or a decrease in SUVmax between
time points 1 and 2, with a
%SUVmax of –21 ±
7.
CONCLUSION. A dual time point improves PET/CT accuracy in patients with a suspected breast malignancy over single-time-point PET/CT. On PET/CT, FDG is increasingly taken up over time in breast tumors; conversely, benign lesions show a decrease in FDG uptake over time. These changes in SUV might represent a reliable parameter that can be used to differentiate benign from malignant lesions of the breast on PET/CT examination.
Keywords: breast carcinoma FDG PET MRI PET/CT
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. Q. Maguire Jr., M. E. Noz, and F. Ponzo Prone Breast Dual-Time-Point PET/CT Compared With MRI for Determining Breast Cancer Am. J. Roentgenol., July 1, 2009; 193(1): W77 - W77. [Full Text] [PDF] |
||||
![]() |
M. Imbriaco, F. Soscia, and G. Avitabile Reply Am. J. Roentgenol., July 1, 2009; 193(1): W78 - W78. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |